Suppr超能文献

抗高血压药物早期和晚期起始与压力感受器反射的比较。

Comparison of early and late start of antihypertensive agents and baroreceptor reflexes.

作者信息

Kumagai K, Suzuki H, Ichikawa M, Jimbo M, Nishizawa M, Ryuzaki M, Saruta T

机构信息

Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.

出版信息

Hypertension. 1996 Feb;27(2):209-18. doi: 10.1161/01.hyp.27.2.209.

Abstract

Along with arterial blood pressure reduction, maintenance of the integrity of baroreceptor reflex function contributes to preserving end-organ function in the treatment of hypertensive patients. The purpose of this study was to investigate the effects of antihypertensive agents (trichlormethiazide, atenolol, nicardipine, and enalapril) on baroreceptor reflex function by comparing early and late starts of treatment. We administered each agent to spontaneously hypertensive rats (SHR) as early-start groups from 10 to 36 weeks of age and as late-start groups from 28 to 36 weeks of age. We evaluated the gain of the reflex control of renal sympathetic nerve activity and heart rate using ramp infusions of phenylephrine and nitroglycerin in untreated SHR at 10, 28, or 36 weeks of age and in treated SHR at 36 weeks of age. In 28- and 36-week-old untreated SHR, the renal sympathetic nerve activity gain was not altered and the heart rate gain was decreased (from -2.3 +/- 0.3 to -1.3 +/- 0.3 and -1.2 +/- 0.3 beats per minute [bm]/mm Hg, P < .05, respectively) compared with 10-week-old SHR. Early and late start of therapy produced arterial pressure reductions (-18 +/- 4 and -12 +/- 5 mm Hg, P < .05, respectively). In the early-start groups, the renal sympathetic nerve activity gain was improved markedly in nicardipine- and enalapril-treated SHR (-4.2 +/- 0.2% and -4.9 +/- 0.2% of control/mm Hg, P < .01, respectively), and the heart rate gain was improved markedly in atenolol- and enalapril-treated SHR (-4.1 +/- 0.2 and -4.4 +/- 0.2 bpm/mm Hg, P < .01, respectively). In the late-start groups, the renal sympathetic nerve activity gain was improved moderately in nicardipine- and enalapril-treated SHR (-3.8 +/- 0.2% and -2.9 +/- 0.2% of control/mm Hg, P < .05, respectively). The heart rate gain was improved slightly only in nicardipine-treated SHR (-1.9 +/- 0.2 bpm/mm Hg, P < .05). These results demonstrate that an early start of antihypertensive treatment improves baroreceptor reflex function markedly compared with a late start of treatment. This supports the hypothesis that a possible critical phase sensitive to intervention with antihypertensive treatment exists during the development of hypertension and indicates that the early start of antihypertensive treatment would be required in clinical practice.

摘要

在高血压患者的治疗中,除了降低动脉血压外,维持压力感受器反射功能的完整性有助于保护终末器官功能。本研究的目的是通过比较治疗的早期启动和晚期启动,研究抗高血压药物(三氯噻嗪、阿替洛尔、尼卡地平和依那普利)对压力感受器反射功能的影响。我们将每种药物给予自发性高血压大鼠(SHR),10至36周龄的作为早期启动组,28至36周龄的作为晚期启动组。我们在10周、28周或36周龄的未治疗SHR以及36周龄的治疗SHR中,使用去氧肾上腺素和硝酸甘油的斜坡输注来评估肾交感神经活动和心率的反射控制增益。在28周龄和36周龄的未治疗SHR中,与10周龄的SHR相比,肾交感神经活动增益未改变,心率增益降低(分别从-2.3±0.3降至-1.3±0.3和-1.2±0.3次/分钟[bm]/mmHg,P<.05)。早期和晚期开始治疗均使动脉压降低(分别为-18±4和-12±5mmHg,P<.05)。在早期启动组中,尼卡地平和依那普利治疗的SHR中肾交感神经活动增益显著改善(分别为对照/mm Hg的-4.2±0.2%和-4.9±0.2%,P<.01),阿替洛尔和依那普利治疗的SHR中心率增益显著改善(分别为-4.1±0.2和-4.4±0.2 bpm/mm Hg,P<.01)。在晚期启动组中,尼卡地平和依那普利治疗的SHR中肾交感神经活动增益适度改善(分别为对照/mm Hg的-3.8±0.2%和-2.9±0.2%,P<.05)。仅在尼卡地平治疗的SHR中心率增益略有改善(-1.9±0.2 bpm/mm Hg,P<.05)。这些结果表明,与晚期开始治疗相比,早期开始抗高血压治疗可显著改善压力感受器反射功能。这支持了在高血压发展过程中存在一个对抗高血压治疗干预敏感的可能关键期的假设,并表明在临床实践中需要早期开始抗高血压治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验